BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16819260)

  • 21. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.
    Szondy Z; Reichert U; Bernardon JM; Michel S; Tóth R; Karászi E; Fésüs L
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):767-74. PubMed ID: 9560303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoid differentiation therapy in promyelocytic leukemia.
    Chomienne C; Fenaux P; Degos L
    FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoid receptors in gastric cancer: expression and influence on prognosis.
    Hu KW; Chen FH; Ge JF; Cao LY; Li H
    Asian Pac J Cancer Prev; 2012; 13(5):1809-17. PubMed ID: 22901127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and stereoselective synthesis of retinoids with ferrocene or N-butylcarbazole pharmacophores that induce post-differentiation apoptosis in acute promyelocytic leukemia cells.
    Ivanova D; Gronemeyer H; de Lera AR
    ChemMedChem; 2011 Aug; 6(8):1518-29. PubMed ID: 21506276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment.
    Park DJ; Chumakov AM; Vuong PT; Chih DY; Gombart AF; Miller WH; Koeffler HP
    J Clin Invest; 1999 May; 103(10):1399-408. PubMed ID: 10330422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Ser(289) in RARgamma and its homologous amino acid residue of RARalpha and RARbeta in the binding of retinoic acid.
    Zhang ZP; Shukri M; Gambone CJ; Gabriel JL; Soprano KJ; Soprano DR
    Arch Biochem Biophys; 2000 Aug; 380(2):339-46. PubMed ID: 10933889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Am80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line.
    Shiohira H; Kitaoka A; Shirasawa H; Enjoji M; Nakashima M
    Int J Mol Med; 2010 Sep; 26(3):393-9. PubMed ID: 20664956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could retinoids be a potential treatment for rheumatic diseases?
    Miyabe Y; Miyabe C; Nanki T
    Rheumatol Int; 2015 Jan; 35(1):35-41. PubMed ID: 24939557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinoids and acute promyelocytic leukemia].
    Hashimoto Y; Shudo K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2203-9. PubMed ID: 1656889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias.
    Muccio DD; Brouillette WJ; Breitman TR; Taimi M; Emanuel PD; Zhang X; Chen G; Sani BP; Venepally P; Reddy L; Alam M; Simpson-Herren L; Hill DL
    J Med Chem; 1998 May; 41(10):1679-87. PubMed ID: 9572893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
    Tallman MS
    Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All trans retinoic acid and cancer.
    Siddikuzzaman ; Guruvayoorappan C; Berlin Grace VM
    Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):241-9. PubMed ID: 20929432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-adult T-cell leukemia effects of a novel synthetic retinoid, Am80 (Tamibarotene).
    Nakazato T; Okudaira T; Ishikawa C; Nakama S; Sawada S; Tomita M; Uchihara JN; Taira N; Masuda M; Tanaka Y; Ohshiro K; Takasu N; Mori N
    Cancer Sci; 2008 Nov; 99(11):2286-94. PubMed ID: 18771528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of the H6-H7 loop in the conformational adaptation of all-trans retinoic acid and synthetic retinoids within the ligand-binding site of RARalpha.
    Mailfait S; Thoreau E; Belaiche D; Formstecher And B Sablonniè P
    J Mol Endocrinol; 2000 Jun; 24(3):353-64. PubMed ID: 10828828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
    Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression.
    Xu K; Guidez F; Glasow A; Chung D; Petrie K; Stegmaier K; Wang KK; Zhang J; Jing Y; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7856-65. PubMed ID: 16140955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases.
    Gianni M; Ponzanelli I; Mologni L; Reichert U; Rambaldi A; Terao M; Garattini E
    Cell Death Differ; 2000 May; 7(5):447-60. PubMed ID: 10800078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.